DrugPatentWatch Database Preview
Drugs in Development Information for Sulodexide
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Sulodexide?
Sulodexide is an investigational drug.
There have been 14 clinical trials for Sulodexide.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2011.
The most common disease conditions in clinical trials are Kidney Diseases, Diabetic Nephropathies, and Albuminuria. The leading clinical trial sponsors are Keryx Biopharmaceuticals, Collaborative Study Group (CSG), and Alfa Wassermann S.p.A.
There are ninety-two US patents protecting this investigational drug and four hundred and thirty-five international patents.
Summary for Sulodexide
| US Patents | 92 |
| International Patents | 435 |
| US Patent Applications | 244 |
| WIPO Patent Applications | 21 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2011-03-01) |
| Vendors | 6 |
Recent Clinical Trials for Sulodexide
| Title | Sponsor | Phase |
|---|---|---|
| Management of Endothelial Dysfunction in Patients With Chronic Venous Insufficiency After Endovenous Surgical Procedure | State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia | N/A |
| Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2) | University Medical Center Groningen | Phase 4 |
| Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2) | Steno Diabetes Center | Phase 4 |
Clinical Trial Summary for Sulodexide
Top disease conditions for Sulodexide
Top clinical trial sponsors for Sulodexide
US Patents for Sulodexide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Sulodexide | Start Trial | Methods, kits and devices for promoting cardiac regeneration | Yeda Research and Development Co. Ltd. (Rehovot, IL) Victor Chang Cardiac Research Institute (Darlinghurst, AU) | Start Trial |
| Sulodexide | Start Trial | Nucleic acid vaccines | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| Sulodexide | Start Trial | Polynucleotides encoding immune modulating polypeptides | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| Sulodexide | Start Trial | Combination PIV3/hMPV RNA vaccines | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| Sulodexide | Start Trial | Human cytomegalovirus RNA vaccines | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Sulodexide
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Sulodexide | Australia | 2015249553 | 2034-04-23 | Start Trial |
| Sulodexide | Brazil | 112016024644 | 2034-04-23 | Start Trial |
| Sulodexide | Canada | 2946751 | 2034-04-23 | Start Trial |
| Sulodexide | China | 106659803 | 2034-04-23 | Start Trial |
| Sulodexide | European Patent Office | 3134131 | 2034-04-23 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
